Toll Free: 1-888-928-9744
Published: Apr, 2015 | Pages:
34 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Deciphera Pharmaceuticals, LLC - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Deciphera Pharmaceuticals, LLC - Product Pipeline Review - 2015', provides an overview of the Deciphera Pharmaceuticals, LLC's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Deciphera Pharmaceuticals, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Deciphera Pharmaceuticals, LLC including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Deciphera Pharmaceuticals, LLC's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Deciphera Pharmaceuticals, LLC's pipeline products Reason To Buy - Evaluate Deciphera Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Deciphera Pharmaceuticals, LLC in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Deciphera Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Deciphera Pharmaceuticals, LLC and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Deciphera Pharmaceuticals, LLC - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Deciphera Pharmaceuticals, LLC and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Deciphera Pharmaceuticals, LLC Snapshot 5 Deciphera Pharmaceuticals, LLC Overview 5 Key Information 5 Key Facts 5 Deciphera Pharmaceuticals, LLC - Research and Development Overview 6 Key Therapeutic Areas 6 Deciphera Pharmaceuticals, LLC - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Out-Licensed Products 11 Out-Licensed Products/Combination Treatment Modalities 12 Deciphera Pharmaceuticals, LLC - Pipeline Products Glance 13 Deciphera Pharmaceuticals, LLC - Clinical Stage Pipeline Products 13 Phase I Products/Combination Treatment Modalities 13 Deciphera Pharmaceuticals, LLC - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Discovery Products/Combination Treatment Modalities 15 Deciphera Pharmaceuticals, LLC - Drug Profiles 16 altiratinib 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 rebastinib tosylate 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 DCC-2618 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 DCC-2721 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 DCC-2909 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 DCC-3014 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Small Molecules to Inhibit Kinase for Oncology 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 DP-3975 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 DP-5599 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Deciphera Pharmaceuticals, LLC - Pipeline Analysis 25 Deciphera Pharmaceuticals, LLC - Pipeline Products by Target 25 Deciphera Pharmaceuticals, LLC - Pipeline Products by Route of Administration 26 Deciphera Pharmaceuticals, LLC - Pipeline Products by Molecule Type 27 Deciphera Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action 28 Deciphera Pharmaceuticals, LLC - Recent Pipeline Updates 29 Deciphera Pharmaceuticals, LLC - Dormant Projects 31 Deciphera Pharmaceuticals, LLC - Locations And Subsidiaries 32 Head Office 32 Other Locations & Subsidiaries 32 Appendix 33 Methodology 33 Coverage 33 Secondary Research 33 Primary Research 33 Expert Panel Validation 33 Contact Us 33 Disclaimer 34
List of Tables
Deciphera Pharmaceuticals, LLC, Key Information 5 Deciphera Pharmaceuticals, LLC, Key Facts 5 Deciphera Pharmaceuticals, LLC - Pipeline by Indication, 2015 8 Deciphera Pharmaceuticals, LLC - Pipeline by Stage of Development, 2015 9 Deciphera Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2015 10 Deciphera Pharmaceuticals, LLC - Out-Licensed Products in Pipeline, 2015 11 Deciphera Pharmaceuticals, LLC - Out-Licensed Products/ Combination Treatment Modalities, 2015 12 Deciphera Pharmaceuticals, LLC - Phase I, 2015 13 Deciphera Pharmaceuticals, LLC - Preclinical, 2015 14 Deciphera Pharmaceuticals, LLC - Discovery, 2015 15 Deciphera Pharmaceuticals, LLC - Pipeline by Target, 2015 25 Deciphera Pharmaceuticals, LLC - Pipeline by Route of Administration, 2015 26 Deciphera Pharmaceuticals, LLC - Pipeline by Molecule Type, 2015 27 Deciphera Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action, 2015 28 Deciphera Pharmaceuticals, LLC - Recent Pipeline Updates, 2015 29 Deciphera Pharmaceuticals, LLC - Dormant Developmental Projects,2015 31 Deciphera Pharmaceuticals, LLC, Other Locations 32
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.